Previous 10 | Next 10 |
2024-06-29 09:11:15 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strateg...
2024-06-29 08:21:00 ET We have closed the books on a strong first half of the year for the U.S. stock market, something that a lot of people overlooked. Now we embark on the second half of the year, which could bring some challenges, though July historically is the market's best-performing ...
2024-06-28 12:45:53 ET More on Johnson & Johnson J&J mid-stage trial for Tremfya against immune disorder fails Johnson & Johnson closes acquisition of biotechnology company Proteologix Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcar...
Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients PR Newswire First-and-only FcRn blocker to demonstrate superiority in activities of daily living (MG-ADL a ) over pl...
2024-06-28 08:27:06 ET Summary The June/July 2024 edition of Fortune Magazine revealed the 500 biggest U.S. companies by-revenue and profits. Dogcatcher’s quest for dividend buys focused-on 66 industry-eaders (IL) using YCharts 6/26/24 data. Those 66 industry-leaders were s...
2024-06-28 03:42:22 ET More on Tractor Supply Tractor Supply + Real Estate Combo: A Recipe For Superior Returns Tractor Supply Q1: Not Buying More For Now But Watching Marjorie Taylor Greene discloses stock purchases Read the full article on Seeking Alpha ...
2024-06-26 22:08:31 ET Summary Dividend stocks are my favored way for generating passive income for retirement. Passive income is generated with minimal effort once set up, and can snowball beautifully as dividends are reinvested. Not all Dividend Aristocrats are good for a ma...
2024-06-25 15:03:18 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strateg...
2024-06-25 06:54:00 ET Investing comes in many flavors, so there isn't a right or wrong approach: You should do what's best for you. That applies even to dividend investing. For some, dividend investing means maximizing immediate income, even if it requires sacrificing some growth and long-...
2024-06-23 11:13:33 ET Summary Since the publication of my last article, Pfizer has continued to surprise me pleasantly. In early May, Pfizer published financial results for the first quarter of 2024, which were enthusiastically received by Wall Street. On June 14, 2024, the c...
News, Short Squeeze, Breakout and More Instantly...
CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study PR Newswire CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S....
2024-07-01 06:50:00 ET Most retirees prefer low turnover in their investment portfolios. The less drama, the better. That way, they can focus on doing what they enjoy instead of worrying about their investments. Three Motley Fool contributors think they've found magnificent stocks retir...
2024-06-29 08:21:00 ET We have closed the books on a strong first half of the year for the U.S. stock market, something that a lot of people overlooked. Now we embark on the second half of the year, which could bring some challenges, though July historically is the market's best-performing ...